2026 reports and submissions

2026 reports and submissions

RACGP submission to the Department of Health, Disability and Ageing (DoHDA) Private Health Reforms – Consultation Paper 1

The RACGP's response emphasises that it is critical to ensure that any reforms strengthen, rather than fragment, continuity of care. GPs play a central role in coordinating care across the health system, and reforms must support timely communication between private hospitals, health services such as Hospital in the Home (HITH), other specialists, allied health and a patient's usual GP.

RACGP response - PBAC review Shingrix vaccine for adults 60+

The RACGP response supports the resubmission by GlaxoSmithKline Australia Pty Ltd to request an expansion to the NIP for recombinant zoster vaccine, Shingrix to include non-indigenous adult patients aged 60 years and over.

RACGP submission – Australian National Audit Office Performance audit: Award of funding for Medicare urgent care clinics

The RACGP’s submission raises concerns that oversights during the establishment of UCCs may contribute to fragmentation of care.

RACGP submission – PBAC review of GLP-1 medicines for type 2 diabetes (November 2026 meeting agenda item)

The RACGP supports the review of prescribing and utilisation patterns for GLP-1 medicines.

Submission to the Department of Health, Disability and Ageing – NDIS access process

The RACGP has provided a response to the DoHDA consultation on the National Disability Insurance Scheme (NDIS) access process.

RACGP response to Fee Transparency in Health Care Consultation – Informed Financial Consent and Split Billing Practices

The RACGP supports informed financial consent and fee transparency and recognises the importance of ensuring patients have access to clear, timely and understandable information about the costs of their healthcare.